Ryan Pawell Talks About Indee Labs’ CRISPR Delivery Technology for Affordable Immunotherapies

May 7, 2020

The mission of Indee Labs, a Berkeley biotech, is to deliver CRISPR reagents into cells using microfluidics for developing affordable cell and gene therapies in the future. We interviewed Ryan Pawell, Founder and CEO of Indee Labs, about the concept of using microfluidics for CRISPR delivery, their mission and ongoing projects, and the convergence of engineering and biology for building scalable platforms.

Play this podcast on Podbean App